Clinical trial
A Pharmacokinetic Study of VinCRIStine in Infants Dosed According to BSA-Banded Infant Dosing Tables and Older Children Dosed by Traditional BSA Methods
NCT05359237 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pharmacokinetic Study of VinCRIStine in Infants Dosed According to BSA-Banded Infant Dosing Tables and Older Children Dosed by Traditional BSA Methods
- Lead sponsor
- Children's Oncology Group
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- November 16, 2022
- Completion date
- September 30, 2026
- Enrollment
- 83 (estimated)
- Sites
- 29
Conditions
As the registry lists them; a condition with its own page is linked.
hematopoietic and lymphoid cell neoplasm, malignant solid neoplasm